These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A study comparing paroxetine placebo and imipramine in depressed patients.
    Author: Feighner JP, Cohn JB, Fabre LF, Fieve RR, Mendels J, Shrivastava RK, Dunbar GC.
    Journal: J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771.
    Abstract:
    These data provide evidence for the antidepressant efficacy of paroxetine. Paroxetine- and imipramine-treated patients were significantly different from placebo-treated patients, but little different to each other, on all depressive outcome measures. However, paroxetine appeared to have a possibly greater and earlier beneficial effect on anxiety symptoms associated with depression, when compared with imipramine. Both active therapies were effective in treating patients with severe depression. Side effects for paroxetine were typical of other serotonin (5-HT) uptake inhibitors but different from those of imipramine. In particular, anticholinergic and cardiovascular symptoms were reduced, and premature withdrawal less likely.
    [Abstract] [Full Text] [Related] [New Search]